Cigna's Evernorth to Scrap Drug Rebate Model for Upfront Discounts — Update

Cigna Group's Evernorth is introducing a rebate-free pharmacy benefit model aimed at reducing drug costs at the counter. This new approach eliminates post-purchase rebates, offering upfront discounts that can lower brand-name prescription costs by an average of 30%. The initiative responds to U.S. drug pricing reforms and will start in January 2026, incorporating technology to compare medication prices. A new reimbursement model for community pharmacies will also be launched, with full adoption by Cigna Healthcare for insured customers in 2027.